Nurix Therapeutics NRIX
NASDAQ NRIX
$23.67 +0.00 (+0.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Current Assets (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) recorded Current Assets of $456.48 million in fiscal Q2 2026 (quarter ended May 31, 2026), down 11.4% from $515.33 million a year earlier and down 17.7% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Current Assets (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics reported Current Assets of $606.82 million, down 2.0% from FY2024.

  • Annual Current Assets has a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
  • Across earlier fiscal years, Current Assets came in at $619.39 million in FY2024 (+109.6%), $295.5 million in FY2023 (-7.2%), $318.45 million in FY2022 (+2.4%) and $311.12 million in FY2021 (+4.3%).
  • Quarterly Current Assets has ranged from $250.97 million in fiscal Q1 2024 to $619.39 million in fiscal Q4 2024 over the past five years.
  • On a year-over-year basis, Current Assets has declined for four consecutive quarters, with growth averaging 37.5% over the last eight quarters.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 124.6% in fiscal Q1 2025, against a decline of 24.5% in fiscal Q3 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $554.39 million (Q1 2026), $606.82 million (Q4 2025) and $440.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Nurix Therapeutics 2.45 Bn 448.58 Mn - 456.48 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 456.48 Mn
Feb 28, 2026 554.39 Mn
Nov 30, 2025 606.82 Mn
Aug 31, 2025 440.60 Mn
May 31, 2025 515.33 Mn
Feb 28, 2025 563.70 Mn
Nov 30, 2024 619.39 Mn
Aug 31, 2024 456.04 Mn
May 31, 2024 450.22 Mn
Feb 29, 2024 250.97 Mn
Nov 30, 2023 295.50 Mn
Aug 31, 2023 267.95 Mn
May 31, 2023 290.01 Mn
Feb 28, 2023 288.33 Mn
Nov 30, 2022 318.45 Mn
Aug 31, 2022 354.87 Mn
May 31, 2022 306.79 Mn
Feb 28, 2022 280.48 Mn
Nov 30, 2021 311.12 Mn
Aug 31, 2021 358.45 Mn
API Access

Nurix Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=NRIX&period=max&api_key=YOUR_API_KEY